logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9314468 B1

PDFFull Text
Date of Patent:
Apr. 19, 2016

Filed:

Nov. 15, 2012

Chemokine receptor modulators

Applicant:

Altiris Therapeutics, Inc., Atlanta, GA (US);

Inventors:

Michael P Clark, Concord, MA (US);

Florence F Wagner, Ashland, MA (US);

Michael G Natchus, Alpharetta, GA (US);

Brandon C Doroh, Duluth, GA (US);

Tricia L Johnson, Union City, GA (US);

Yesim Altas Tahirovic, Decatur, GA (US);

Lawrence Wilson, Atlanta, GA (US);

John M Wiseman, Atlanta, GA (US);

Jason W Skudlarek, Suwanee, GA (US);

Mark A Lockwood, Alpharetta, GA (US);

Assignee:

Altiris Therapeutics, Inc., Atlanta, GA (US);

Attorney:

King & Spalding

Primary Examiner:

Shengjun Wang

Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 31/535 (2006.01); A61K 31/497 (2006.01); A61K 31/541 (2006.01); C07D 403/14 (2006.01); C07D 487/04 (2006.01); A61K 31/437 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/541 (2013.01); A61K 31/437 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 401/12 (2013.01); C07D 403/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

The invention provides compounds of Formula (I) and pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, and/or esters thereof. These compounds, and pharmaceutical composition comprising such compounds are useful treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers.

Find Patent Forward Citations

Loading…